SEC Form 4 · accession 0000939798-19-000005
GT Biopharma, Inc. · GTBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tony Cataldo
Director
Period of report
Feb 6, 2019
Accepted (ET)
Feb 13, 2019 · 11:22 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000109657
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stockF1 | Feb 6, 2019 | S | 800,000 | $0.001 | D | 4,029,600 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This a stock pledge for nominal consideration in a private transaction for a personal family matter.